Evidence map›Paper›PMID 26670619›Full record

ReviewPharmaceutical patent analyst2016

Fluorine-18 patents (2009-2015). Part 1: novel radiotracers.

Allen F Brooks, Lindsey R Drake, Megan N Stewart, Brian P Cary, Isaac M Jackson, Dale Mallette, Andrew V Mossine, Peter J H Scott

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceutical patent analyst, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Allen F BrooksDepartment of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA.
Lindsey R DrakeDepartment of Medicinal Chemistry, University of Michigan, 428 Church St., Ann Arbor, MI 48109, USA.
Megan N StewartDepartment of Medicinal Chemistry, University of Michigan, 428 Church St., Ann Arbor, MI 48109, USA.
Brian P CaryDepartment of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA.
Isaac M JacksonDepartment of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA.
Dale MalletteDepartment of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA.
Andrew V MossineDepartment of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA.
Peter J H ScottDepartment of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA.

Funding

INTERDEPARTMENTAL TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007767 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ISOM, LORI L. · 1985 to 2019
$10.2M
Training Future Imaging Scientists for BiomedicineT32EB005172 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FOWLKES, JEFFREY B · 2008 to 2012
$1.1M
NIBIB NIH HHS T32 EB005172NIBIB NIH HHS T32-EB005172NIGMS NIH HHS T32 GM007767NIGMS NIH HHS T32-GM007767
6 · The paper itself

Abstract

The most commonly utilized PET radionuclide is fluorine-18 ((18)F) because of its convenient half-life and excellent imaging properties. In this review, we present the first analysis of patents issued for radiotracers labeled with fluorine-18 (between 2009 and 2015), and provide perspective on current trends and future directions in PET radiotracer development.

Indexed as

Fluorine RadioisotopesRadiopharmaceuticalsAnimalsHeart DiseasesHumansNeoplasmsNervous System DiseasesNeuroimagingPatents as TopicRadionuclide ImagingFluorine RadioisotopesRadiopharmaceuticals

Identifiers

PMID26670619
PMCPMC5561792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.